How Center Volumes Affect Early Outcomes in Acute Myeloid Leukemia

Clin Lymphoma Myeloma Leuk. 2015 Nov;15(11):646-54. doi: 10.1016/j.clml.2015.07.646. Epub 2015 Aug 5.

Abstract

Early mortality (EM) is all too frequent during induction chemotherapy for acute myeloid leukemia. Older patients shoulder an undue amount of this burden as a result of the inherent biology of their disease and increased comorbidities. EM rates in academic centers have seen a sharp decline over the past 20 years; however, data from population-based registries show that EM rates for the general population have significantly lagged behind. In this review, we analyze the data available on EM in academic centers and the general population, explore recent improvements in supportive care and the use of predictive models, and finally investigate the relationship between case volume and complications during chemotherapy.

Keywords: Academic center and population data; Early mortality; Geriatric assessments; Predictive models; Supportive care.

Publication types

  • Review

MeSH terms

  • Academic Medical Centers* / statistics & numerical data
  • Age Factors
  • Comorbidity
  • Disease Management
  • Humans
  • Incidence
  • Infections / diagnosis
  • Infections / etiology
  • Infections / therapy
  • Leukemia, Myeloid, Acute / complications
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / epidemiology*
  • Leukemia, Myeloid, Acute / mortality
  • Models, Theoretical
  • Mortality
  • Outcome Assessment, Health Care*
  • Population Surveillance
  • Quality of Health Care